US20030133939A1 - Binding domain-immunoglobulin fusion proteins - Google Patents

Binding domain-immunoglobulin fusion proteins Download PDF

Info

Publication number
US20030133939A1
US20030133939A1 US10/053,530 US5353002A US2003133939A1 US 20030133939 A1 US20030133939 A1 US 20030133939A1 US 5353002 A US5353002 A US 5353002A US 2003133939 A1 US2003133939 A1 US 2003133939A1
Authority
US
United States
Prior art keywords
ser
gt
lt
immunoglobulin
binding domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/053,530
Inventor
Jeffrey Ledbetter
Martha Hayden-Ledbetter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emergent Product Development Seattle LLC
Original Assignee
Genecraft Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US36735801P priority Critical
Application filed by Genecraft Inc filed Critical Genecraft Inc
Priority to US10/053,530 priority patent/US20030133939A1/en
Assigned to GENECRAFT, INC. reassignment GENECRAFT, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HAYDEN-LEDBETTER, MARTHA S., LEDBETTER, JEFFREY A.
Priority claimed from US10/207,655 external-priority patent/US7754208B2/en
Publication of US20030133939A1 publication Critical patent/US20030133939A1/en
Priority claimed from US10/627,556 external-priority patent/US7829084B2/en
Assigned to TRUBION PHARMACEUTICALS, INC. reassignment TRUBION PHARMACEUTICALS, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: GENECRAFT, INC.
Assigned to EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC reassignment EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC MERGER (SEE DOCUMENT FOR DETAILS). Assignors: TRUBION PHARMACEUTICALS, INC.
Application status is Abandoned legal-status Critical

Links